Sumitomo Pharma America, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1984-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.sunovion.com
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 386
- Registration Number
- NCT00073840
- Locations
- 🇺🇸
Aeroallergy Research Laboratories of Savannah, Inc., Savannah, Georgia, United States
🇺🇸Rush Presbyterian - St. Luke's Medical Center Rush University, Chicago, Illinois, United States
🇺🇸Research Across America, Dallas, Texas, United States
Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2003-12-10
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT00073814
- Locations
- 🇺🇸
The Children's Clinic of Jonesboro, PA, Jonesboro, Arkansas, United States
🇺🇸Madera Family Medical Group, Madera, California, United States
🇺🇸Bellevue Pediatric Association, Pittsburgh, Pennsylvania, United States
Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 746
- Registration Number
- NCT00064389
- Locations
- 🇺🇸
Allergy & Asthma Research of NJ, Inc., Philadelphia, Pennsylvania, United States
🇨🇦Primary Care Lung Clinic, Toronto, Ontario, Canada
🇺🇸Alta Clinical Research, LLC, Tucson, Arizona, United States
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
- Conditions
- Chronic Obstructive Pulmonary DiseaseChronic BronchitisEmphysema
- Interventions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 741
- Registration Number
- NCT00064402
- Locations
- 🇺🇸
Advances in Medicine, Rancho Mirage, California, United States
🇺🇸Office of Bradley Sakran, MD, PC, O'Fallon, Illinois, United States
🇺🇸University of Maryland-Airways Research Center, Baltimore, Maryland, United States
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD
- Conditions
- Chronic Obstructive Pulmonary DiseaseChronic BronchitisEmphysema
- Interventions
- First Posted Date
- 2003-07-09
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 799
- Registration Number
- NCT00064415
- Locations
- 🇺🇸
Advances in Medicine, Rancho Mirage, California, United States
🇺🇸Inland Clinical Research, Inc., Riverside, California, United States
🇺🇸New Horizon Health Research, Atlanta, Georgia, United States
Safety and Tolerability Study of Drug to Treat Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2002-08-20
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT00044005
- Locations
- 🇺🇸
University of California, Irvine, Orange, California, United States
🇺🇸University of South Florida, Tampa, Florida, United States
🇺🇸Lake Mead Hospital, North Las Vegas, Nevada, United States
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2002-08-20
- Last Posted Date
- 2014-04-17
- Lead Sponsor
- Sumitomo Pharma America, Inc.
- Target Recruit Count
- 356
- Registration Number
- NCT00044044
- Locations
- 🇺🇸
Alexian Brothers Behavioral Health Hospital, Hoffman Estates, Illinois, United States
🇺🇸ClinSearch, Inc., Kenilworth, New Jersey, United States
🇺🇸Claghorn Lesem Research Clinic, Inc., Bellaire, Texas, United States